$ZIOP ZIOPHARM ONCOLOGY INC Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ZIOPHARM ONCOLOGY INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in ZIOPHARM ONCOLOGY INC. Find out how many shares they currently own, their value and whether they buy or sell their shares.
ZIOPHARM ONCOLOGY INC Insiders
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| ABERCROMBIE GEORGE B | Director | 25,000 | 167,500 | Apr 06 2010 | |||
| Amello Jason | Executive Vice President & CFO | 22,377 | 149,926 | May 14 2013 | |||
| BAGLEY RICHARD E | President, COO & Treasurer | 175,000 | 1,172,500 | Sep 24 2009 | |||
| BAGLEY RICHARD E | President, CCO & Treasurer | 0 | 0 | Jul 01 2008 | |||
| BAGLEY RICHARD E | President, CCO & Treasurer | 75,000 | 502,500 | Dec 05 2008 | |||
| BAGLEY RICHARD E | President, COO & Treasurer | 153,767 | 1,030,239 | Jan 04 2011 | |||
| BAGLEY RICHARD E | President, COO & Treasurer | 211,239 | 1,415,301 | Jan 04 2012 | |||
| BELBEL CAESAR J | COO, CLO, and Secretary | 260,551 | 1,745,692 | Jan 03 2018 | |||
| BELBEL CAESAR J | EVP, Chief Legal Officer & Sec | 0 | 0 | Sep 06 2011 | |||
| BELBEL CAESAR J | EVP, CLO, and Secretary | 23,802 | 159,473 | Jan 02 2015 | |||
| Bowden Christopher | Director | 4,167 | 27,919 | May 06 2021 | |||
| Braunstein Scott | Director | 31,780 | 212,926 | Jan 03 2020 | |||
| BRENNAN MURRAY | Director | 74,814 | 501,254 | Nov 22 2017 | |||
| BRENNAN MURRAY | Director | 0 | 0 | Jan 04 2012 | |||
| BRENNAN MURRAY | Director | 0 | 0 | Jan 02 2015 | |||
| BUCHI J KEVIN | Director | 4,167 | 27,919 | May 06 2021 | |||
| Buck Jill | EVP, GM Gene Therapy | 231,016 | 1,547,807 | Mar 08 2021 | |||
| CANNON JAMES ANTHONY | Director | 398,050 | 2,666,935 | May 08 2019 | |||
| Cooper Laurence James Neil | President and CEO | 1,799,280 | 12,055,176 | Jan 06 2021 | |||
| De Groot Eleanor | EVP, GM Cell Therapy | 257,238 | 1,723,495 | Mar 08 2021 | |||
| ESSEX WOODLANDS HEALTH VENTURES FUND VI L P | 10% Owner | 1,913,876 | 12,822,969 | Feb 23 2007 | |||
| ESSEX WOODLANDS HEALTH VENTURES FUND VI L P | 10% Owner | 2,371,642 | 15,890,001 | Dec 10 2009 | |||
| Ezickson Elan | Director | 111,994 | 750,360 | Jan 03 2020 | |||
| Fowler Wyche | Director | 163,328 | 1,094,298 | Jan 03 2018 | |||
| Fowler Wyche | Director | 72,500 | 485,750 | Aug 11 2011 | |||
| Fowler Wyche | Director | 15,000 | 100,500 | Dec 05 2008 | |||
| Fowler Wyche | Director | 113,366 | 759,552 | Jan 02 2015 | |||
| FRAGIN GARY S | Director | 67,500 | 452,250 | Apr 01 2010 | |||
| GALE ROBERT PETER | Senior V.P. of Research | 0 | 0 | Apr 27 2006 | |||
| Hadfield Robert | Chief Legal Officer and Sec. | 176,819 | 1,184,687 | Mar 08 2021 | |||
| Hagen Heidi | Interim CEO | 122,119 | 818,197 | Mar 08 2021 | |||
| Huang James | Director | 8,333 | 55,831 | May 06 2021 | |||
| KIRK RANDAL J | Director | 139,513 | 934,737 | Oct 09 2018 | |||
| KIRK RANDAL J | Director | 17,830,305 | 119,463,044 | Feb 10 2015 | |||
| KIRK RANDAL J | Director | 95,648 | 640,842 | Jan 05 2015 | |||
| Lafond Kevin G | SVP, Treasurer & CAO | 63,965 | 428,566 | Jan 12 2021 | |||
| Lafond Kevin G | Vice Pres., Treasurer, & CAO | 26,666 | 178,662 | Jan 02 2015 | |||
| LEBEL FRANCOIS | Executive Vice President R&D | 159,350 | 1,067,645 | Jan 04 2017 | |||
| LEWIS JONATHAN | CEO | 479,510 | 3,212,717 | Jan 11 2011 | |||
| LEWIS JONATHAN | CEO | 744,145 | 4,985,772 | Jan 02 2015 | |||
| MAUNEY DAVID M MD | President | 275,778 | 1,847,713 | Jan 31 2020 | |||
| MCINERNEY TIMOTHY | Director | 59,205 | 396,674 | Sep 15 2005 | |||
| MCINERNEY TIMOTHY | Director | 78,205 | 523,974 | Dec 05 2008 | |||
| MCINERNEY TIMOTHY | Director | 372,120 | 2,493,204 | Jan 02 2015 | |||
| Pagan Douglas W. | Director | 55,997 | 375,180 | Jan 03 2020 | |||
| Postma Robert W | Director | 1,181,362 | 7,915,125 | May 06 2021 | |||
| ROSENWALD LINDSAY A MD | 10% Owner | 0 | 0 | May 05 2006 | |||
| Shukla Sath | EVP, Chief Financial Officer | 80,500 | 539,350 | Jan 31 2020 | |||
| Tarriff Scott | Director | 4,186 | 28,046 | Jan 03 2020 | |||
| Thistle Mary | Director | 5,000 | 33,500 | May 06 2021 | |||
| Vieser Jaime | Director | 605,321 | 4,055,651 | May 06 2021 | |||
| Weis Holger | Director | 70,167 | 470,119 | May 06 2021 | |||
| WEISER MICHAEL | Director | 230,303 | 1,543,030 | Jan 03 2018 | |||
| WEISER MICHAEL | Director | 0 | 0 | May 15 2009 | |||
| WEISER MICHAEL | Director | 0 | 0 | Dec 17 2007 | |||
| WEISER MICHAEL | Director | 83,445 | 559,082 | May 19 2006 | |||
| WEISER MICHAEL | Director | 98,445 | 659,582 | Dec 05 2008 | |||
| WEISER MICHAEL | Director | 150,945 | 1,011,332 | Apr 01 2010 | |||
| WEISER MICHAEL | Director | 135,945 | 910,832 | May 26 2011 | |||
| WEISER MICHAEL | Director | 166,934 | 1,118,458 | Jan 02 2015 | |||
| Youssoufian Hagop | Executive VP, CMO | 50,000 | 335,000 | Jul 18 2011 | |||
| Youssoufian Hagop | Executive VP, CMO | 115,380 | 773,046 | Jan 04 2012 | |||
| Youssoufian Hagop | President of R&D and CMO | 92,721 | 621,231 | Jan 03 2013 |